A rapidly gelling synthetic tissue sealant was developed from tetra-succini
midyl and tetra-thiol-derivatized polyethylene glycol (PEG). The two reagen
ts were dissolved in aqueous buffers at 20% (w/v) solids and sprayed on the
tissue site, with the use of a sprayer/mixer device. Good adhesion to coll
agen membranes, PTFE grafts, and carotid artery was observed in vitro. In a
burst test on collagen membranes with a 2-mm orifice defect, the gel susta
ined fluid pressures of 125 +/- 36 mm Hg (n = 18), fivefold greater than ca
pillary blood pressure and one-half that observed in hypertension. On 0.4-m
m-diameter puncture defects in PTFE grafts, pressures of 390-490 mm Hg were
sustained, and on 0.6-0.9-mm puncture defects in carotid arteries, pressur
es of 490 to 840 mm Hg were sustained. In vitro data corresponded to result
s in vivo, where bleeding in rabbit arteries was stopped immediately in fiv
e out of six trials. A significant reduction in time to hemostasis and bloo
d loss, compared to controls, was observed. Carotid artery and subcutaneous
implant data in rabbits showed that the formula was compatible with biolog
ical tissue. Rapid gelling and effective sealing were dependent on the pres
ence of active succinimidyl ester and thiol groups on PEG. HPLC and chemica
l substitution methods were useful in predicting whether batches of derivat
ized PEG would perform satisfactorily. (C) 2001 John Wiley & Sons, Inc.